当前位置:首页 - 行情中心 - 力生制药(002393) - 财务分析

力生制药

(002393)

  

流通市值:51.87亿  总市值:53.35亿
流通股本:2.50亿   总股本:2.58亿

力生制药(002393)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.74亿元,每股收益1.44元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益500333.33万元,未分配利润173637.04万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产592118.27万元,负债91784.94万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,007,280,440.26731,508,082.68369,840,643.71,336,154,449.87
营业总成本871,042,976.72619,756,337.76305,793,020.681,211,524,253.09
其他经营收益
营业利润446,001,766.23413,984,329.7167,216,791.48221,650,720.22
利润总额433,014,784.98401,448,134.0167,360,477.12215,948,800.36
净利润374,284,895.92345,337,466.3756,570,945.05185,960,824.83
每股收益
其他综合收益----174,730,748.26
综合收益总额374,284,895.92345,337,466.3756,570,945.0511,230,076.57
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,145,046,672.583,165,213,428.553,066,995,612.163,059,714,286.07
非流动资产:
非流动资产合计2,776,136,038.32,788,602,958.762,709,079,907.492,725,797,526.21
资产总计5,921,182,710.885,953,816,387.315,776,075,519.655,785,511,812.28
流动负债:
流动负债合计680,470,444.16684,749,598.05707,592,100.78746,527,866.55
非流动负债:
非流动负债合计237,378,925.95231,308,973.32239,247,706.21239,008,753.33
负债合计917,849,370.11916,058,571.37946,839,806.99985,536,619.88
所有者权益(或股东权益):
归属于母公司股东权益合计4,969,564,6675,005,174,621.814,797,881,012.734,769,916,090.81
股东权益合计5,003,333,340.775,037,757,815.944,829,235,712.664,799,975,192.4
负债和股东权益合计5,921,182,710.885,953,816,387.315,776,075,519.655,785,511,812.28
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,121,837,852.3765,550,357.76310,886,048.281,368,335,162.17
经营活动现金流出小计997,018,255.74695,719,531.64311,863,659.861,280,071,805.76
经营活动产生的现金流量净额124,819,596.5669,830,826.12-977,611.5888,263,356.41
投资活动产生的现金流量:
投资活动现金流入小计2,399,500,287.931,998,086,866.421,249,819,229.11,999,668,452.61
投资活动现金流出小计2,749,588,301.942,282,162,197.421,149,142,930.372,258,755,773.71
投资活动产生的现金流量净额-350,088,014.01-284,075,331100,676,298.73-259,087,321.1
筹资活动产生的现金流量:
筹资活动现金流入小计87,156,317.9772,156,317.9761,104,30039,750,000
筹资活动现金流出小计229,807,502.38224,300,382.61103,995,214.11213,926,918.12
筹资活动产生的现金流量净额-142,651,184.41-152,144,064.64-42,890,914.11-174,176,918.12
汇率变动对现金及现金等价物的影响-2,566.09-441.85-745.47
现金及现金等价物净增加额-367,922,167.95-366,389,011.3756,807,773.04-345,000,137.34
期末现金及现金等价物余额1,227,242,885.761,228,776,042.341,651,972,826.751,595,165,053.71
补充资料:
现金及现金等价物的净增加额--366,389,011.37--345,000,137.34
TOP↑